Handelsbanken Fonder
NTUS

Handelsbanken Fonder’s Natus Medical Inc NTUS Stock Holding History

Handelsbanken Fonder’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,130
Closed -$266K – 1619
2022
Q2 		$266K Sell
8,130
-4,800
-37% -$152K ﹤0.01% 1394
2022
Q1 		$340K Hold
12,930
– – ﹤0.01% 1451
2021
Q4 		$307K Hold
12,930
– – ﹤0.01% 1607
2021
Q3 		$324K Hold
12,930
– – ﹤0.01% 1569
2021
Q2 		$336K Buy
+12,930
New +$352K ﹤0.01% 1595

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Handelsbanken Fonder's NTUS Position: Q3 2022 in Review

Handelsbanken Fonder sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 8,130 shares — an estimated $266K sold.

Handelsbanken Fonder first reported a position in NTUS in Q2 2021 and held it in 5 quarters. The position peaked at $340K in Q1 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Handelsbanken Fonder reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Handelsbanken Fonder sold 8,130 Natus Medical Inc shares in Q3 2022, an estimated $266K.
  • Handelsbanken Fonder first reported a position in Natus Medical Inc in Q2 2021 and held it in 5 quarters.
  • Handelsbanken Fonder's Natus Medical Inc position peaked at $340K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Handelsbanken Fonder's 13F filing for Q3 2022, filed 27 Oct 2022.